These novel therapies, including Wegovy, Mounjaro , and Zaxig , represent a major advancement in treating type 2 the condition and assisting with weight prohibitin targeting peptide loss . They work by mimicking the body’s natural peptide GLP-1 , assisting to control blood sugar and reduce cravings. The drug has somewhat unique properties and may